It has been reported that PPARδ can improve hepatic steatosis by activating fatty acid β-oxidation in different diet-induced models of steatohepatitis (NASH, obesity and insulin resistance)39–41. Here, PPARD is linked to obesity due to melanocortin 4 receptor deficiency.